Holen Sie sich die Stockscreener-App
187.06
0.09%
-0.03
Handel nachbörslich:
187.10
0.04
+0.02%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Astrazeneca Plc Aktie (AZN) Neueste Nachrichten
AstraZeneca Unit Keeps Cancer Therapy IP Despite Stada Jab - Law360
Astrazeneca Pharma India March-quarter PAT 448.8 million rupees - marketscreener.com
AstraZeneca breast cancer drug camizestrant recommended for EU approval - Investing.com
Datroway extends survival in TNBC as AstraZeneca (NYSE: AZN) gains US ok - Stock Titan
AstraZeneca's Buy Rating Reiterated as BofA Notes 'Busy' Pipeline Path; Estimates Revised - marketscreener.com
CHMP backs AstraZeneca (AZN) and Daiichi Sankyo’s Enhertu for HER2‑positive solid tumours in EU - Stock Titan
AstraZeneca plc stock (GB0009895292): oncology approvals and home-market context for UK investors - AD HOC NEWS
Oncology Medicine Development Keeps AstraZeneca Within FTSE 350 - Kalkine Media
AstraZeneca (LSE:AZN) Draws Market Focus as Share Momentum Moderates - Kalkine Media
AstraZeneca PLC stock (US6549022043): cancer portfolio and pipeline in focus after latest oncology d - AD HOC NEWS
AstraZeneca PLC stock (US6549022043): cancer pipeline and diabetes deal keep investors watching - AD HOC NEWS
EU panel backs AstraZeneca breast cancer drug camizestrant By Investing.com - Investing.com Nigeria
AstraZeneca's Enhertu Recommended For EU Approval In HER2-positive Solid Tumours - DirectorsTalk Interviews
AstraZeneca says Datroway approved in US for 1L triple-negative BC - marketscreener.com
Sir Pascal Soriot: Veterinary Scientist, Pharmaceutical Transformer, and Executive Director and CEO of AstraZeneca - BBN Times
AstraZeneca plc stock (GB0009895292): FDA approval for Datroway puts oncology pipeline in the spotli - AD HOC NEWS
AstraZeneca Maintains FTSE Presence Through Oncology and Global Healthcare - Kalkine Media
AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC - Pharmaceutical Technology
AstraZeneca PLC (AZN) Stock Analysis: Strong Buy Ratings And A 20% Upside Potential - DirectorsTalk Interviews
Phillips Wealth Planners LLC's AstraZeneca PLC(AZN) Holding History - GuruFocus
AstraZeneca stock (US6549022043): New drug and earnings updates keep investors focused - AD HOC NEWS
Why Are Rolls-Royce and AstraZeneca Trending - Kalkine Media
Why is AstraZeneca attracting healthcare discussion across the United Kingdom market? - Kalkine Media
AstraZeneca Expands Healthcare Presence Across FTSE 100 Pharmaceutical - Kalkine Media
AstraZeneca: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins - Seeking Alpha
AstraZeneca plc stock (GB0009895292): FDA approvals and oncology pipeline keep investors watching - AD HOC NEWS
AstraZeneca PLC stock (US6549022043): FDA decisions and oncology pipeline keep investors alert - AD HOC NEWS
AstraZeneca Plc (LSE:AZN) Share Price, History, & News - twelfthmagpie.com
AstraZeneca wins FDA AdCom backing for Truqap in prostate cancer - MSN
AstraZeneca PLC stock (US6549022043): insider sale and oncology spotlight draw investor attention - AD HOC NEWS
Insider Sell: Mani Sharma Sells Shares of AstraZeneca PLC - GuruFocus
XXI WEALTH, LLC's AstraZeneca PLC(AZN) Holding History - GuruFocus
AstraZeneca (AZN) officer Sharma Mani sells 11,893 Ordinary Shares in open market - Stock Titan
FTSE 100 Closes Week Upbeat; AstraZeneca Sees Oncology Approval Progress - Yahoo Finance UK
EU regulator backs approval for AstraZeneca's experimental breast cancer pill - Reuters
AstraZeneca and Daiichi cancer drugs clear regulatory hurdles - London South East
AstraZeneca PLC stock (US6549022043): oncology growth and new approvals keep investors watching - AD HOC NEWS
Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates - AstraZeneca
Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive metastatic solid tumours - AstraZeneca
CT UK Capital underperforms as underweight on AstraZeneca, Shell - marketscreener.com
AZN News | ASTRAZENECA PLC (NYSE:AZN) - ChartMill
AstraZeneca plc stock (GB0009895292): Deutsche Bank reiterates Sell despite strong analyst consensus - AD HOC NEWS
AZN Stock Quote Price and Forecast - CNN
AstraZeneca plc stock (GB0009895292): Deutsche Bank reiterates Sell rating as pipeline and US listin - AD HOC NEWS
AstraZeneca PLC stock (US6549022043): analysts update views as pipeline news keeps investors alert - AD HOC NEWS
ASTRAZENECA : Deutsche Bank reiterates its Sell rating - marketscreener.com
AstraZeneca stock holds steady after net debt rises £2.5 billion following dividend payment - Traders Union
AZN Technical Analysis | Trend, Signals & Chart Patterns | ASTRAZENECA PLC (NYSE:AZN) - ChartMill
Research Alert: CFRA Adds Shares Of Astrazeneca Plc To The Total Return Portfolio - 富途牛牛
How VEPPANU Approval Frames Expectations For AstraZeneca’s Camizestrant In ESR1 Disease - Yahoo Finance
AstraZeneca plc stock (GB0009895292): Latest catalyst after recent company news - AD HOC NEWS
ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight - GlobeNewswire Inc.
AstraZeneca PLC stock (US6549022043): US drug approvals keep Big Pharma name in focus - AD HOC NEWS
AZN Stock Price and Chart — LSE:AZN - TradingView
AstraZeneca’s Earnings Call Balances Growth and Risk - TipRanks
AstraZeneca plc stock (GB0009895292): oncology momentum and new data keep investors watching - AD HOC NEWS
AstraZeneca plc stock (GB0009895292): US drug approvals keep pharma giant in focus - AD HOC NEWS
AstraZeneca stock (GB0009895292): lung cancer data and Q1 update keep focus on oncology pipeline - AD HOC NEWS
AstraZeneca PLC stock (US6549022043): US drug approvals and oncology milestone keep pipeline in focu - AD HOC NEWS
FDA approves AstraZeneca’s new kind of hypertension drug - BioPharma Dive
Flat trading for AstraZeneca stock as GBX13,902 resistance keeps gains in check - Traders Union
AstraZeneca plc stock (GB0009895292): US drug approvals trigger milestone payment and fresh attentio - AD HOC NEWS
AstraZeneca’s New FDA Wins Raise Questions On Growth And Valuation - Yahoo Finance
AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology PortfoliosAstraZeneca (NYSE:AZN) - Benzinga
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):